Alert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
Ordering can continue through fax and phone.
Contact us
Alert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
Ordering can continue through fax and phone.
Contact usAlert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
.Ordering can continue through fax and phone.
Contact usThis page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}. You’re currently on the {originCountryName} site. Do you want to switch to a different country site?
BD partners across all stages of the drug development process, supporting leading biopharmaceutical companies and CROs globally to advance companion diagnostics development programs with cutting edge single-cell technologies/analysis and scientific collaboration from discovery to market approval and commercialization.
BD has over 125 years of experience in the medical device market and is on the forefront of using flow cytometry as a CDx modality. Our dedicated team of CDx experts, with global footprint and regulatory experience, is ready to partner with you to develop, validate and position your CDx for a successful day-one launch.
Explore the possibilities of BD Biosciences flow cytometry and single cell analysis solutions in cell therapy research, including manufacturing QC.